Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • arrchi
    Member
    • Mar 2011
    • 46

    #1

    cuffcompare <outprefix>.stats question

    Hi there,

    The values in the outprefix.stats of my cuffcompare are very low. Here is an example:

    #cuffcompare -V -r hg19.ensembl-for-tophat.gtf transcripts.gtf
    #

    #= Summary for dataset: transcripts.gtf :
    # Query mRNAs : 65495 in 64983 loci (5211 multi-exon transcripts)
    # (421 multi-transcript loci, ~1.0 transcripts per locus)
    # Reference mRNAs : 99330 in 43503 loci (82822 multi-exon)
    # Corresponding super-loci: 5232
    #--------------------| Sn | Sp | fSn | fSp
    Base level: 4.6 17.3 - -
    Exon level: 0.9 4.3 1.4 6.5
    Intron level: 2.5 80.2 2.5 81.7
    Intron chain level: 0.1 1.4 0.2 2.6
    Transcript level: 0.0 0.0 0.0 0.0
    Locus level: 0.2 0.1 0.2 0.2
    Missed exons: 333400/353286 ( 94.4%)
    Wrong exons: 56158/73680 ( 76.2%)
    Missed introns: 262639/272474 ( 96.4%)
    Wrong introns: 790/8364 ( 9.4%)
    Missed loci: 36101/43503 ( 83.0%)
    Wrong loci: 54293/64983 ( 83.5%)

    Total union super-loci across all input datasets: 59557
    Have anyone seen such low values? Does 94.4% means my data could not map to 94.4% of exons on my reference genome? What does "Wrong exons" mean?

    Thanks for any input!
    -A

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...